China Universal Asset Management Co., Ltd. Arbutus Biopharma Corp Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 40,179 shares of ABUS stock, worth $132,188. This represents 0.01% of its overall portfolio holdings.
Number of Shares
40,179
Previous 36,309
10.66%
Holding current value
$132,188
Previous $139,000
5.76%
% of portfolio
0.01%
Previous 0.02%
Shares
15 transactions
Others Institutions Holding ABUS
# of Institutions
170Shares Held
101MCall Options Held
674KPut Options Held
682K-
Morgan Stanley New York, NY22.6MShares$74.3 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.2MShares$43.6 Million22.74% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$38 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.98MShares$29.5 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.74MShares$28.8 Million4.68% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $493M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...